Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis

Shao-Hung Wang1, Chen Zhang, Mark E Lasbury

  • 1Department of Medical Research, E-DA Hospital, I-Shou University, Kaohsiung 824, Taiwan, ROC.

Microbes and Infection
|April 11, 2008
PubMed

Insights

Toll-like receptor 2 (TLR2) deficiency in mice reduced lung inflammation during Pneumocystis pneumonia (PcP). However, it also increased parasite burden, indicating TLR2 plays a role in clearing Pneumocystis.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Pneumocystis pneumonia (PcP) causes significant lung inflammation and injury.
  • Toll-like receptor 2 (TLR2) is known to mediate macrophage inflammatory responses to Pneumocystis.

Purpose of the Study:

  • To investigate the role of TLR2 in the host response to Pneumocystis pneumonia.
  • To determine if TLR2 deficiency impacts lung inflammation and parasite clearance.

Main Methods:

  • Histopathology examination of lungs from wild-type and TLR2-/- mice infected with Pneumocystis.
  • Measurement of inflammatory markers such as TNF-alpha and NF-kappaB activation.
  • Assessment of organism burden and expression of protective mechanism-related genes (iNOS, p47phox).

Main Results:

  • TLR2-/- mice with PcP showed reduced pulmonary inflammation and lower levels of TNF-alpha and NF-kappaB activation.
  • Conversely, TLR2-/- mice exhibited increased PcP symptom severity and higher Pneumocystis organism burden.
  • Decreased mRNA levels of inducible nitric oxide synthase (iNOS) and NADPH oxidase p47phox, along with lower nitric oxide levels, were observed in TLR2-/- PcP mice.

Conclusions:

  • TLR2-mediated inflammation contributes to lung injury in PcP but is also essential for controlling Pneumocystis organism burden.
  • TLR2 plays a dual role in PcP, modulating both inflammation and parasite clearance through mechanisms involving iNOS and NADPH oxidase.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...